Laurion Capital Management LP Infla Rx N.V. Transaction History

Laurion Capital Management LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.78 - $1.9 $189,094 - $460,615	-242,429 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$1.83 - $4.48 $471,354 - $1.15 Million	-257,571 Reduced 51.51%	242,429 $444,000
Q1 2021 May 14, 2021	BUY	$3.62 - $6.34 $1.81 Million - $3.17 Million	500,000 New	500,000 $1.95 Million
Q1 2018 May 14, 2018	SELL	$20.21 - $32.0 $326,916 - $517,632	-16,176 Closed	0 $0
Q4 2017 Feb 13, 2018	BUY	$14.55 - $23.99 $235,360 - $388,062	16,176	16,176 $339,000

13.2M

5.2K

Ticker IFRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 44,203,800
Market Cap $67.6M
Description
InflaRx N.V., a clinical-stage biopharmaceutical company, discovers and develops inhibitors using C5a technology primarily in Germany and the United States. The company's C5a is an inflammatory mediator that is involved in the progression of a variety of autoimmune and other inflammatory diseases. Its lead product candidate is vilobelimab, a nov...

Get notified when there are updates to the investment portfolio of Laurion Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Laurion Capital Management LP with notifications on news.